Major surgery within  weeks of first dose of study drug
Major surgery within  weeks before the first dose of study drug
Major surgery, radiation, or treatment with any other investigational drug within  weeks of study treatment
Prior major treatment-related surgery completed at least  weeks prior to study drug administration;
Major surgery within  weeks of the first dose of study drug
Has had major surgery within  weeks before first study drug administration
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of first dose of study drug
Any major surgery within  weeks prior to the first dose of study drug.
CRITERIA SPECIFIC FOR COHORT # (MCL): Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks prior to first dose of study drug
Major surgery within  weeks of initiation of study drug
Major surgery within  weeks prior to registration or first dose of drug
Major surgery within  weeks prior to first dose of study drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of initiation of study drug
Major surgery less than  weeks prior to the first dose of study drug; minor surgery less than  weeks prior to the first dose of study drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks before first dose of study drug
Major surgery within  weeks of first dose of study drug
Subjects who have had major surgery (such as nephrectomy) or chemotherapy within  weeks prior to first dose of drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of drug administration
Had major surgery within  weeks prior to study drug treatment.
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of first dose of study drug
Subjects who have had major surgery within  weeks prior to first dose of drug
Major surgery within  weeks of study enrollment or planned major surgery during study and up to  months after discontinuation of study drug
Major surgery within  weeks of first dose of study drug
Has had major surgery to liver or other site within  weeks prior to the first dose of study drug.
Major surgery within  weeks prior to first dose of study drug.
Major surgery within  weeks before first dose of study drug.
Major surgery within  weeks before first dose of study drug.
major surgery within  weeks of first dose of study drug
Major surgery within  weeks of the first dose of study drug
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks before the first dose of study drug.
Major surgery within  weeks of first dose of study drug.
Major surgery within  weeks of first dose of study drug
Major surgery within six weeks or open biopsy within  days before drug infusion.
Trauma or major surgery within  weeks of first study drug administration
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of study drug administration
Had major surgery within  weeks of first dose of study drug
Subjects who had major surgery within  weeks of the first day of study drug.
Major surgery within  weeks of the first dose of study drug.
Major surgery within  weeks prior to first study drug administration
Subjects that have undergone major surgery within  weeks prior to the first dose of study drug are not eligible
Major surgery within  weeks before first dose of study drug.
Major surgery within  weeks before the first dose of study drug.
Major surgery within  weeks before first day of study drug dosing
Major surgery or radiation therapy within  weeks before first study drug administration.
Major surgery planned within  weeks of the first dose of study drug
Major surgery within  weeks prior to first study drug administration.
Major surgery within  weeks of st dose of study drug
Major surgery within  weeks of first dose of study drug.
Major surgery within  weeks of initiation of study drug
Major surgery within six weeks or open biopsy within  days before drug infusion.
Major surgery within  weeks before the first dose of either study drug
Major surgery or significant trauma within  weeks prior to the first dose of study drug.
Prior major surgery within  weeks of starting study drug administration
Trauma or major surgery within  weeks of first study drug administration
Major surgery within  weeks of first dose of study drug
Major surgery within  weeks of first dose of study drug
EXCLUSION CRITERIA (PRIOR TO IBRUTINIB ADMINISTRATION): Major surgery within  weeks of first dose of study drug
Had major surgery within  weeks before study drug treatment
Major surgery within  weeks of first dose of study drug
History of severe trauma or major surgery within  weeks prior to the initiation of study drug administration.